Unwavering Dedication This month, we are proud to honor Sushma Rani Shekhar, a woman whose leadership, integrity, and unwavering dedication have not only benefited our team but also inspired those around her. Sushma’s is an example of dedication to Celegence’s Human Resources division. Breaking Down Barriers Overcoming gender discrimination and achieving
"Truly Inspiring" In the dynamic field of life sciences, there are individuals whose dedication and passion not only elevate their work but also inspire those around them. This month, we are proud to honor Smridula Hariharan, an example of excellence and leadership in the Medical Device Services division. Smridula’s colleagues describe
MBE Certification Renewal 2024 Celegence, led by Sonia Veluchamy, is proud to announce that as of February 16, 2024, we are re-certified by the National Minority Supplier Development Council (NMSDC) as a Minority Business Enterprise (MBE) for the second consecutive year. This prestigious certification is a testament to our commitment to diversity, inclusion,
Reimagining the Future of Scientific Writing Reimagining the Future of Scientific Writing, CAPTIS Copilot leverages cutting-edge AI models for the Medical Device and Diagnostic Industry Chicago, IL – August 2, 2023. Celegence, a regulatory compliance service and software solution company, today announced the launch of CAPTIS Copilot, the most advanced document automation
Celegence Certified as a Minority-Owned Business by the NMSDC Chicago, IL, January 11th, 2023 - Celegence, a global provider of regulatory affairs services and solutions for the life sciences industry, has been recently granted Minority Business Enterprise (MBE) Certification by the Chicago Minority Supplier Development Council. The certification verifies Celegence’s status of being at
CAPTIS™ Selected for Performance Evaluation Reports and other PMS Documentation Celegence, a global provider of regulatory affairs services for the life sciences industry, is pleased to announce that Navignostics, a global developer of drug mechanisms designed to identify ideal treatments for cancer patients, has selected Celegence’s CAPTIS™ technology solution to support Performance Evaluation
Celegence Unveils Next Level Efficiencies for eCTD Compliance with New Functionality Added to Dossplorer™ Celegence, a global provider of regulatory affairs services and solutions for the life sciences industry has added new functionality to Dossplorer™, its advanced, cloud-based dossier management solution. Dossplorer™ from Qdossier, a Celegence company enables users to create transparency, consistency,
Celegence Acquires Qdossier Chicago, IL, July 18th, 2022 - Celegence, a global provider of regulatory affairs services and solutions for the life sciences industry, has today announced the acquisition of Qdossier, a supplier of end-to-end services to support document and dossier lifecycle management for pharmaceutical products. Qdossier also provides leading cloud-based technology, which creates
Celegence adds report writing functionality to EU MDR and IVDR compliance technology, CAPTIS™ Chicago, July 6th, 2022 - Celegence, a global provider of regulatory affairs services and solutions for the life sciences industry, has today announced the addition of new features to CAPTIS™ to help the device and diagnostic industry produce compliant Post
Celegence Partner with RAPS for Webinar On "Taking Advantage of the EU MDR Delay in Uncertain Times" Celegence (Headquartered in Chicago, Illinois) is presenting a webinar with RAPS, the largest global organization of and for those involved with the regulation of healthcare and related products, including medical devices, pharmaceuticals, biologics and nutritional products. Join
